Clinical Trial Update: Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase II trial investigating neoadjuvant metronomic chemotherapy in triple-negative breast cancer was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Leo W. Jenkins Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-09-10